There have been 50 recent insider transactions recorded for Clearside Biomedical, Inc. (CLSD), including 38 buys and 9 sells. Total insider buying was valued at $4.55M and total insider selling at $136.04K.
Notable insiders with recent activity include Thorp Clay, Lasezkay George M, Deignan Charles A.. Insider transactions can provide insights into how company leadership views the stock's valuation and future prospects.
Insider Transactions — CLSD
| Date |
Name |
Role |
Transaction |
Shares |
Avg. Price |
Value |
Shares Owned |
| 2025-02-24 |
Thorp Clay |
Director |
Informative Buy |
15,000 |
$0.92 |
$13.8K |
176,141 |
| 2025-01-08 |
Lasezkay George M |
CEO |
RSU Award |
500,000 |
$0.97 |
$485K |
500,000 |
| 2025-01-08 |
Deignan Charles A. |
Chief Financial Officer |
RSU Award |
200,000 |
$0.97 |
$194K |
200,000 |
| 2025-01-08 |
Chong Ngai Hang Victor |
Chief Medical Officer |
RSU Award |
250,000 |
$0.97 |
$242.5K |
250,000 |
| 2024-11-01 |
Chong Ngai Hang Victor |
Chief Medical Officer |
Informative Buy |
36,500 |
$1.00 |
$36.5K |
100,000 |
| 2024-06-24 |
Chong Ngai Hang Victor |
Chief Medical Officer |
Informative Buy |
23,500 |
$1.06 |
$24.91K |
63,500 |
| 2024-06-20 |
Yerxa Benjamin R |
Director |
RSU Award |
45,000 |
$1.15 |
$51.75K |
45,000 |
| 2024-06-20 |
Shaffer Christy L |
Director |
RSU Award |
45,000 |
$1.15 |
$51.75K |
45,000 |
| 2024-06-20 |
Edwards Jeffrey L |
Director |
RSU Award |
45,000 |
$1.15 |
$51.75K |
45,000 |
| 2024-06-20 |
Hutson Nancy J |
Director |
RSU Award |
45,000 |
$1.15 |
$51.75K |
45,000 |
| 2024-06-20 |
Thorp Clay |
Director |
RSU Award |
45,000 |
$1.15 |
$51.75K |
45,000 |
| 2024-06-20 |
Croarkin Richard |
Director |
RSU Award |
45,000 |
$1.15 |
$51.75K |
45,000 |
| 2024-06-20 |
Humphries William D. |
Director |
RSU Award |
45,000 |
$1.15 |
$51.75K |
45,000 |
| 2024-06-20 |
Gibney Anthony S |
Director |
RSU Award |
45,000 |
$1.15 |
$51.75K |
45,000 |
| 2024-05-15 |
Yerxa Benjamin R |
Director |
Informative Buy |
7,813 |
$1.31 |
$10.24K |
17,957 |
| 2024-04-18 |
Gibney Anthony S |
Director |
Informative Buy |
93,290 |
$1.30 |
$121.28K |
100,000 |
| 2024-04-17 |
Gibney Anthony S |
Director |
Informative Buy |
6,710 |
$1.25 |
$8.39K |
6,710 |
| 2024-04-15 |
Gibney Anthony S |
Officer |
Unknown |
- |
- |
- |
- |
| 2024-04-15 |
Gibney Anthony S |
Director |
RSU Award |
45,000 |
$1.29 |
$58.05K |
45,000 |
| 2024-03-20 |
Chong Ngai Hang Victor |
Chief Medical Officer |
Informative Buy |
30,000 |
$1.60 |
$48K |
30,000 |
| 2024-03-18 |
Chong Ngai Hang Victor |
Chief Medical Officer |
RSU Award |
450,000 |
$1.56 |
$702K |
450,000 |
| 2024-03-14 |
Chong Ngai Hang Victor |
Officer |
Unknown |
- |
- |
- |
- |
| 2024-03-14 |
Chong Ngai Hang Victor |
Chief Medical Officer |
Disposition |
- |
- |
- |
10,000 |
| 2024-02-07 |
Whitmore Bradford T |
10 Percent Owner |
Informative Buy |
444,444 |
$1.62 |
$720K |
444,444 |
| 2024-01-19 |
Lasezkay George M |
CEO |
Informative Sell |
18,000 |
$1.27 |
$22.86K |
466,577 |
| 2024-01-19 |
Deignan Charles A. |
Chief Financial Officer |
Informative Sell |
12,900 |
$1.28 |
$16.51K |
384,662 |
| 2024-01-18 |
Lasezkay George M |
CEO |
RSU Award |
439,500 |
$1.29 |
$566.96K |
439,500 |
| 2024-01-18 |
Deignan Charles A. |
Chief Financial Officer |
RSU Award |
200,000 |
$1.29 |
$258K |
200,000 |
| 2023-11-01 |
Whitmore Bradford T |
10 Percent Owner |
Informative Buy |
64,366 |
$0.74 |
$47.9K |
4,050,590 |
| 2023-10-31 |
Whitmore Bradford T |
10 Percent Owner |
Informative Buy |
70,812 |
$0.73 |
$51.54K |
3,986,224 |
| 2023-10-30 |
Whitmore Bradford T |
10 Percent Owner |
Informative Buy |
600 |
$0.69 |
$411.00 |
3,915,412 |
| 2023-10-27 |
Whitmore Bradford T |
10 Percent Owner |
Unknown |
- |
- |
- |
2,350,152 |
| 2023-10-03 |
Hutson Nancy J |
Director |
Informative Buy |
10,000 |
$0.86 |
$8.6K |
93,000 |
| 2023-09-25 |
Thorp Clay |
Director |
Informative Buy |
10,000 |
$0.86 |
$8.6K |
40,522 |
| 2023-09-22 |
Humphries William D. |
Director |
Option Exercise (Sell) |
22,727 |
$0.40 |
$9.09K |
- |
| 2023-09-18 |
Lasezkay George M |
CEO |
RSU Award |
200,000 |
$0.85 |
$169.8K |
200,000 |
| 2023-09-18 |
Deignan Charles A. |
Chief Financial Officer |
RSU Award |
100,000 |
$0.85 |
$84.9K |
100,000 |
| 2023-09-13 |
Deignan Charles A. |
Chief Financial Officer |
Option Exercise (Sell) |
34,090 |
$0.40 |
$13.64K |
- |
| 2023-06-22 |
Yerxa Benjamin R |
Director |
RSU Award |
30,000 |
$1.31 |
$39.3K |
30,000 |
| 2023-06-22 |
Shaffer Christy L |
Director |
RSU Award |
30,000 |
$1.31 |
$39.3K |
30,000 |
| 2023-06-22 |
Edwards Jeffrey L |
Director |
RSU Award |
30,000 |
$1.31 |
$39.3K |
30,000 |
| 2023-06-22 |
Hutson Nancy J |
Director |
RSU Award |
30,000 |
$1.31 |
$39.3K |
30,000 |
| 2023-06-22 |
Thorp Clay |
Director |
RSU Award |
30,000 |
$1.31 |
$39.3K |
30,000 |
| 2023-06-22 |
Croarkin Richard |
Director |
RSU Award |
30,000 |
$1.31 |
$39.3K |
30,000 |
| 2023-06-22 |
Humphries William D. |
Director |
RSU Award |
30,000 |
$1.31 |
$39.3K |
30,000 |
| 2023-01-20 |
Ciulla Thomas |
Chief Medical Officer |
Informative Sell |
13,700 |
$1.47 |
$20.14K |
291,890 |
| 2023-01-19 |
Lasezkay George M |
CEO |
Informative Sell |
20,030 |
$1.46 |
$29.24K |
484,577 |
| 2023-01-19 |
Deignan Charles A. |
Chief Financial Officer |
Informative Sell |
14,030 |
$1.50 |
$21.05K |
363,472 |
| 2023-01-10 |
Ciulla Thomas |
Chief Medical Officer |
Informative Sell |
2,170 |
$1.62 |
$3.52K |
305,590 |
| 2023-01-04 |
Lasezkay George M |
CEO |
RSU Award |
487,500 |
- |
- |
487,500 |
■ Informative Buy/Sell — open market transaction (most significant)
■ Uninformative Buy — award, option exercise, conversion
■ Uninformative Sell — tax withholding, award vest sale
■ Neutral — gift, trust, expiry
